PHARMACIE DEMAN
ActiveSummary
The computed 12-month bankruptcy probability of PHARMACIE DEMAN is 2.2% (moderate). For PHARMACIE DEMAN, at least two annual filings are missing. The 2023 annual accounts show equity of €54,987 and a net result of €1,255. Equity has been shrinking by about 9.3% per year since 2018. Its solvency ranks better than 95% of 6,527 sector peers (NACE 47, financial year 2023). The company has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 28-12-1983 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.023.760.092 6141 Fontaine-l'Evêque, since 28-12-1983
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 2.2%
- Gross margin
- €4,048
- ▼ 85.9%
- Turnover
- ≈ €43,000
- estimated
- Profit
- €1,255
- ▼ 95.5%
- Equity
- €54,987
- ▲ 2.3%
- Total assets
- €56,059
- ▼ 8.8%
- 2024 accounts not filed, 460 days past the deadline
Signalsraises riskFigures for financial year 2023 (filed on 25-06-2024)2 financial years not filed after the legal deadline; 2 of the last 3 accounts lateSize: total assets €56,059Two or more financial years not filedlowers riskLiquidity: current ratio 48.49, cash €51,312neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 55 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
Key points
- Positive: Higher solvency than 95% of companies in retail tradesector median 32.1% · 6,527 companies 98.1% View
Comparable companies
These companies have the same main activity as PHARMACIE DEMAN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €27,100 and €113,000, founded between 1974 and 1998.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMACIE DEMAN Ham-sur-Heure-Nalinnes | €56,059 | €4,048 |
| SIRRAH Tournai | €73,766 | €3,402 |
| APOTHEEK MEMBRUGGEN Riemst | €89,331 | €4,286 |
| Pharmacie LEFEBVRE Leuven | €112,505 | €3,365 |
| Apotheek Spaanse Kroon Leuven | €110,316 | €4,464 |
| PHARMACIE BAILLY Ellezelles | €93,414 | €1,725 |
| Jeûne & Hormèse Chaudfontaine | €27,054 | €5,520 |
Key facts about PHARMACIE DEMAN
- What is the company number of PHARMACIE DEMAN?
- The company number of PHARMACIE DEMAN is 0425.157.829. The VAT number is the same number with BE in front: BE 0425.157.829.
- Where is PHARMACIE DEMAN based?
- The registered office is at Rue Richard Carlier(HSH) 53, 6120 Ham-sur-Heure-Nalinnes.Company details
- What does PHARMACIE DEMAN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHARMACIE DEMAN?
- The legal form of PHARMACIE DEMAN is Public limited company (NV).
- When was PHARMACIE DEMAN founded?
- PHARMACIE DEMAN was founded on 28-12-1983.
- Is PHARMACIE DEMAN still active?
- Yes, PHARMACIE DEMAN is an active enterprise in the KBO register.
- What is the turnover of PHARMACIE DEMAN?
- The turnover in financial year 2023 is ≈ €43,000. This figure is estimated from the gross margin of €4,048 and 49 comparable companies (NACE 477). It probably lies between €22,000 and €110,000. It is a rough estimate. In financial year 2019 turnover was €1,512.Financials
- Is PHARMACIE DEMAN profitable?
- In financial year 2023, PHARMACIE DEMAN made a profit of €1,255.
- Where can I find the annual accounts of PHARMACIE DEMAN?
- PHARMACIE DEMAN filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2023.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.